160 related articles for article (PubMed ID: 19364649)
1. Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones.
Zhao XZ; Maddali K; Vu BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2009 May; 19(10):2714-7. PubMed ID: 19364649
[TBL] [Abstract][Full Text] [Related]
2. Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality.
Zhao XZ; Maddali K; Marchand C; Pommier Y; Burke TR
Bioorg Med Chem; 2009 Jul; 17(14):5318-24. PubMed ID: 19527935
[TBL] [Abstract][Full Text] [Related]
3. 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors.
Zhao XZ; Semenova EA; Vu BC; Maddali K; Marchand C; Hughes SH; Pommier Y; Burke TR
J Med Chem; 2008 Jan; 51(2):251-9. PubMed ID: 18095643
[TBL] [Abstract][Full Text] [Related]
4. Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
Zhao XZ; Maddali K; Metifiot M; Smith SJ; Vu BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2011 May; 21(10):2986-90. PubMed ID: 21493066
[TBL] [Abstract][Full Text] [Related]
5. 6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors.
Zhao XZ; Metifiot M; Smith SJ; Maddali K; Marchand C; Hughes SH; Pommier Y; Burke TR
Curr Top Med Chem; 2016; 16(4):435-40. PubMed ID: 26268341
[TBL] [Abstract][Full Text] [Related]
6. Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase.
Métifiot M; Maddali K; Johnson BC; Hare S; Smith SJ; Zhao XZ; Marchand C; Burke TR; Hughes SH; Cherepanov P; Pommier Y
ACS Chem Biol; 2013 Jan; 8(1):209-17. PubMed ID: 23075516
[TBL] [Abstract][Full Text] [Related]
7. Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.
Zeng LF; Jiang XH; Sanchez T; Zhang HS; Dayam R; Neamati N; Long YQ
Bioorg Med Chem; 2008 Aug; 16(16):7777-87. PubMed ID: 18644730
[TBL] [Abstract][Full Text] [Related]
8. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
[TBL] [Abstract][Full Text] [Related]
10. 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
Billamboz M; Bailly F; Lion C; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; De Luca L; Chimirri A; Cotelle P
Eur J Med Chem; 2011 Feb; 46(2):535-46. PubMed ID: 21185110
[TBL] [Abstract][Full Text] [Related]
11. 3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.
Tang J; Maddali K; Metifiot M; Sham YY; Vince R; Pommier Y; Wang Z
J Med Chem; 2011 Apr; 54(7):2282-92. PubMed ID: 21381765
[TBL] [Abstract][Full Text] [Related]
12. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
[TBL] [Abstract][Full Text] [Related]
14. 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.
Zhao XZ; Maddali K; Smith SJ; Métifiot M; Johnson BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2012 Dec; 22(24):7309-13. PubMed ID: 23149229
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro protoporphyrinogen oxidase inhibition, and herbicidal activity of N-(benzothiazol-5-yl)hexahydro-1H-isoindole-1,3-diones and N-(benzothiazol-5-yl)hexahydro-1H-isoindol-1-ones.
Wu QY; Jiang LL; Zuo Y; Wang ZF; Xi Z; Yang GF
Chem Biol Drug Des; 2014 Oct; 84(4):431-42. PubMed ID: 24803371
[TBL] [Abstract][Full Text] [Related]
16. [Design, synthesis of quinolinone acid-containing compounds with anti-HIV integrase activity].
Chen XF; Wu YB; Jin J; Wang RZ; Wang C; Liu J
Yao Xue Xue Bao; 2010 Feb; 45(2):263-7. PubMed ID: 21351438
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
[TBL] [Abstract][Full Text] [Related]
18. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
19. Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: azoles: effective metal chelators.
Le G; Vandegraaff N; Rhodes DI; Jones ED; Coates JA; Thienthong N; Winfield LJ; Lu L; Li X; Yu C; Feng X; Deadman JJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5909-12. PubMed ID: 20727753
[TBL] [Abstract][Full Text] [Related]
20. Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor.
Vandurm P; Cauvin C; Guiguen A; Georges B; Le Van K; Martinelli V; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Bioorg Med Chem Lett; 2009 Aug; 19(16):4806-9. PubMed ID: 19556126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
